Novo Nordisk Foundation - The International Diabetes Consortium (IDNC)

The International Diabetic Neuropathy Consortium (IDNC)

This grant was awarded by the Novo Nordisk Foundation to Dr. Eva Feldman. The study will look at the presence and absence of certain metabolites in the blood of both mouse models and humans with type 2 diabetes. The goal is to search for specific patterns of metabolites, or “signature,” of diabetes and to identify targets to develop treatments.